A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Recruiting · NCT06306456 · Registry updated 2024-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC | Non-Small Cell Lung Cancer With EGFR Mutation | Recruiting | Phase 1 / Phase 2 | 2024-07-08 | NCT06306456 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Genhouse Bio Co., Ltd. | 6 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hunan Cancer Hospital | Changsha | China | 27 |
| Nanjing Drum Tower Hospital | Nanjing | China | 52 |
| Shanghai Pulmonary Hospital | Shanghai | China | 72 |
| Taizhou Hospital of Zhejiang Province | Linhai | China | 1 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 56 |
| The Second Hospital of Anhui Medical University | Hefei | China | 25 |